iASPP and chemoresistance in ovarian cancers: effects on paclitaxel-mediated mitotic catastrophe.

iASPP and chemoresistance in ovarian cancers: effects on paclitaxel-mediated mitotic catastrophe.

PURPOSE: iASPP is a specific regulator of p53-mediated apoptosis. Herein, we provided the first report on the expression profile of iASPP in ovarian epithelial tumor and its effect on paclitaxel chemosensitivity. EXPERIMENTAL DESIGN: Expression and amplification status of iASPP was examined in 203...

Full description

Bibliographic Details
Main Authors:	Jiang, L, Siu, M, Wong, O, Tam, K, Lu, X, Lam, E, Ngan, H, Le, X, Wong, E, Monteiro, L, Chan, H, Cheung, A
Format:	Journal article
Language:	English
Published:	2011

Similar Items

Overexpression of iASPP is required for autophagy in response to oxidative stress in choriocarcinoma
by: Ka-Kui Chan, et al.
Published: (2019-10-01)

Investigating the role of iASPP and ASPP2 in human carcinoma
by: Salter, V
Published: (2014)

iASPP in the balance between tolerance and autoimmunity
by: Akama-Garren, E
Published: (2017)

Effect of iASPP RNAi vector transfection on apoptosis of MCF-7
by: Hou, L, et al.
Published: (2008)

Regulation of immunological tolerance by the p53-inhibitor iASPP
by: Akama-Garren, EH, et al.
Published: (2023)

Nuclear iASPP may facilitate prostate cancer progression.
by: Morris, E, et al.
Published: (2014)

Investigation of the biological role of iASPP in vivo
by: Notari, M
Published: (2011)

Investigating the role of iASPP in cutaneous disorders
by: Dedeić, Z
Published: (2014)

Effect of RNA interference of iASPP on the apoptosis in MCF-7 breast cancer cells.
by: Liu, Z, et al.
Published: (2008)

Investigating the role of iASPP in skin homeostasis and tumourigenesis
by: Chung, HKK
Published: (2014)

Regulation of immunological tolerance by the p53-inhibitor iASPP
by: Elliot H. Akama-Garren, et al.
Published: (2023-02-01)

Cell autonomous role of iASPP deficiency in causing cardiocutaneous disorders
by: Dedeić, Z, et al.
Published: (2018)

Investigating the role of iASPP in normal prostate development and prostate tumourigenesis
by: Morris, E, et al.
Published: (2013)

iASPP regulates neurite development by interacting with Spectrin proteins
by: Junhao Wang, et al.
Published: (2023-05-01)

Original paper<br>The leukemogenic role of (iASPP) in acute leukemia
by: Sohier Abdel Almawgood, et al.
Published: (2007-06-01)

Caspase cleavage of iASPP potentiates its ability to inhibit p53 and NF-κB.
by: Hu, Y, et al.
Published: (2015)

p53 inhibitor iASPP is an unexpected suppressor of KRAS and inflammation-driven pancreatic cancer
by: Miller, P, et al.
Published: (2023)

The N-terminus of a novel isoform of human iASPP is required for its cytoplasmic localization
by: Slee, EA, et al.
Published: (2004)

iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human.
by: Bergamaschi, D, et al.
Published: (2003)

Downregulation of ASPP1 in gestational trophoblastic disease: Correlation with hypermethylation, apoptotic activity and clinical outcome
by: Mak, V, et al.
Published: (2011)

Downregulation of ASPP1 in gestational trophoblastic disease: correlation with hypermethylation, apoptotic activity and clinical outcome.
by: Mak, VC, et al.
Published: (2011)

Inhibitor of apoptosis-stimulating protein of p53 (iASPP) prevents senescence and is required for epithelial stratification.
by: Notari, M, et al.
Published: (2011)

Downregulation of ASPP2 in choriocarcinoma contributes to increased migratory potential through Src signaling pathway activation.
by: Mak, VC, et al.
Published: (2013)

Hyaluronan-Induced CD44-iASPP Interaction Affects Fibroblast Migration and Survival
by: Chun-Yu Lin, et al.
Published: (2023-02-01)

The prolyl isomerase Pin1 orchestrates p53 acetylation and dissociation from the apoptosis inhibitor iASPP.
by: Mantovani, F, et al.
Published: (2007)

iASPP mediates p53 selectivity through a modular mechanism fine-tuning DNA recognition
by: Chen, S, et al.
Published: (2019)

Mutant Ras and inflammation-driven skin tumorigenesis is suppressed via a JNK-iASPP-AP1 axis
by: Al Moussawi, K, et al.
Published: (2022)

Inhibitor of apoptosis-stimulating protein of p53 (iASPP) is required for neuronal survival after axonal injury.
by: Ariel M Wilson, et al.
Published: (2014-01-01)

iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72-polymorphic p53.
by: Bergamaschi, D, et al.
Published: (2006)

Nuclear iASPP determines cell fate by selectively inhibiting either p53 or NF-κB
by: Wenjie Ge, et al.
Published: (2021-07-01)

Inhibitory member of the apoptosis-stimulating proteins of the p53 family (iASPP) interacts with protein phosphatase 1 via a noncanonical binding motif.
by: Llanos, S, et al.
Published: (2011)

Sertad1 antagonizes iASPP function by hindering its entrance into nuclei to interact with P53 in leukemic cells
by: Shaowei Qiu, et al.
Published: (2017-11-01)

Restoring p53 function in human melanoma cells by inhibiting MDM2 and cyclin B1/CDK1-phosphorylated nuclear iASPP.
by: Lu, M, et al.
Published: (2013)

Correction: restoring p53 function in human melanoma cells by inhibiting MDM2 and cyclin B1/CDK1-phosphorylated nuclear iASPP
by: Lu, M, et al.
Published: (2016)

Rationale for combination of paclitaxel and CDK4/6 inhibitor in ovarian cancer therapy — non-mitotic mechanisms of paclitaxel
by: Elizabeth R. Smith, et al.
Published: (2022-09-01)

Linkage disequilibrium mapping of a breast cancer susceptibility locus near <it>RAI/PPP1R13L/iASPP</it>
by: Mains Mette, et al.
Published: (2008-06-01)

TGFBI promoter hypermethylation correlating with paclitaxel chemoresistance in ovarian cancer
by: Wang Ning, et al.
Published: (2012-01-01)

An antimitotic and antivascular agent BPR0L075 overcomes multidrug resistance and induces mitotic catastrophe in paclitaxel-resistant ovarian cancer cells.
by: Xiaolei Wang, et al.
Published: (2013-01-01)

ASPP [corrected] and cancer.
by: Trigiante, G, et al.
Published: (2006)

iASPP induces EMT and cisplatin resistance in human cervical cancer through miR-20a-FBXL5/BTG3 signaling
by: Ying Xiong, et al.
Published: (2017-04-01)